Offer - Urjas Oil for just ₹ 1 X
Aloja Tablet is an allopathic medicine The correct dosage of Aloja Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Aloja Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Aloja Tablet safe for pregnant women?
There are no side effects of Aloja Tablet in pregnant women.
Is the use of Aloja Tablet safe during breastfeeding?
Aloja Tablet does not show any side effects in breastfeeding women.
What is the effect of Aloja Tablet on the Kidneys?
Aloja Tablet rarely affects the kidneys.
What is the effect of Aloja Tablet on the Liver?
Very few cases of side effects of Aloja Tablet on the liver have been reported.
What is the effect of Aloja Tablet on the Heart?
Aloja Tablet has very mild side effects on the heart.
Aloja Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Aloja Tablet unless your doctor advises you to do so -
Is this Aloja Tablet habit forming or addictive?
Forming a habit of Aloja Tablet has not been reported.
Interaction between Food and Aloja Tablet
There is no information on the effects of taking Aloja Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Aloja Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Aloja Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Precose® (acarbose tablets)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Ultravist® (Iopromide)